4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-22-026344
Chief Development Officer acquired 185,605 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Machatha Stephen Chief Development Officer | 2022-07-15 | Grant or award | +185,605 | 273,263 | D | ||
| Derivatives | |||||||
| Machatha Stephen Chief Development Officer | 2022-07-15 | Grant or award · Bonus Units | +69,473 | 69,473 | D | ||
Loading xslF345X03/doc4.xml…